President’s Message: Progress in Mitigating the Negative Effects of the “Opioid Crisis”

Harry J. Gould, III, MD, PhD On June 26, 2021, Johnson & Johnson confirmed that in 2020, as part of a $230M settlement with the State of New York, they discontinued promotion and distribution of opioid products in the State of New York. The settlement was made in response to efforts to mitigate the unprecedented […] Read More

Long Haul COVID-19

Olivia Lee and Lawrence Robbins, MD Introduction Over 325 million doses of COVID-19 vaccines have been distributed in the United States, and much of the country is looking forward to a return to normalcy. For many, the widespread access to vaccines signaled the pandemic’s defeat, but for millions of COVID-19 survivors, the sequelae following acute […] Read More

ANA2021 Registration Is Now Open!

ANA2021’s Virtual Annual Meeting is set for October 17-19 with an Opening Symposium on October 16 and registration is now open! All full registrations include access to the ANA2021 Meeting Recordings package, ensuring you won’t miss out on the latest neurological research even if your schedule should change. Registration also includes complimentary access to the SIG Series […] Read More